Live slow-frozen human tumor tissues scRNA
Bam files of 17 samples from 11 different patients. The scRNAseq data were obtained using the 10X 3' Gene Expression kit.
- 12/08/2024
- 17 samples
- DAC: EGAC00001002819
- Technology: Illumina NovaSeq 6000
Data Access policy of the Live slow-frozen project
In signing this agreement, you are agreeing to be bound by the terms and conditions of access set out in this agreement. In signing this Agreement: 1. You, the Data Recipient, agree to only use the Data for the Purpose of the Project. 2. You agree to use the data only for the advancement of medical research, according to the consent obtained from sample donors. 3. You agree not to use the data for the creation of products for sale or for any commercial purpose. 4. You agree to preserve, at all times, the confidentiality of information and Data pertaining to Data Subjects. In particular, you undertake not to use, or attempt to use the Data to compromise or otherwise infringe the confidentiality of information on Data Subjects and their right to privacy. 5. You agree not to attempt to link the data provided under this agreement to other information or archive data available for the data sets provided, even if access to that data has been formally granted to you, or it is freely available without restriction, without specific permission being sought from the relevant access committees. 6. You agree not to transfer or disclose the data, in whole or part, or any identifiable material derived from the Data, to others, except as necessary for data/safety monitoring or program management. Should you wish to share the Data with a collaborator, the third party must make a separate application for access to the data. 7. You agree to use the data for the approved purpose and project described in your application; use of the data for a new purpose or project will require a new application and approval. 8. You agree to acknowledge in any work based in whole or part on the data, the published paper from which the data derives, and the repository it was obtained from. 9. You accept that the Data Access Committee, the original data creators, depositors or copyright holders, or the funders of the data or any part of the data supplied: a) bear no legal responsibility for the accuracy or comprehensiveness of the data; and b) accept no liability for indirect, consequential, or incidental, damages or losses arising from use of the data, or from the unavailability of, or break in access to, the data for whatever reason. 10. You understand and acknowledge that the data is protected by copyright and other intellectual property rights, and that duplication, except as reasonably required to carry out your research with the data, or sale of all or part of the data on any media is not permitted. 11. You recognize that nothing in this agreement shall operate to transfer to the Data Recipient any intellectual property rights relating to the data. The Data Recipient has the right to develop intellectual property based on comparisons with their own data. 12. You accept that this agreement will terminate immediately upon any breach of this agreement by you, and you will be required to destroy any data held. 13. You accept that it may be necessary for the Data Access Committee or its appointed agent to alter the terms of this agreement from time to time in order to address new concerns. In this event, the Data Access Committee or its appointed agent will contact you to inform you of any changes and you agree that your continued use of the data shall be dependent on the parties entering into a new version of the Agreement. 14. You agree that you will submit a report to the Data Access Committee, if requested, on completion of the agreed purpose. The Data Access Committee agrees to treat the report and all information, data, results, and conclusions contained within such report as confidential information belonging to the Data Recipient. 15. You shall ensure that ‘all’ who have Access to the Data, namely You and Your Authorised Personnel, will be listed out, and are made aware and be bound by the terms of this Agreement. You remain solely and fully responsible for Your Authorised Personnel’s non-compliance with the provision of the Agreement and/or applicable laws. 16. In case of a breach of security resulting from ‘accidental’ use of Data by You and Your Authorised Personnel, which leads to disclosure of Data, then You must report this to Data Controller(s) within 72 hours maximum, and follow any relevant rule as provided by the GDPR. 17. You accept that the data is protected by and subject to international laws, including but not limited to the Swiss Human Research Act, and that you are responsible for ensuring compliance with any such applicable law. The Data Access Committee reserves the right to request and inspect data security and management documentation to ensure the adequacy of data protection measures in countries that have no national laws comparable to that which pertain in the EAA. 18. This agreement shall be construed, interpreted and governed by the laws of Switzerland and shall be subject to the non-exclusive jurisdiction of Swiss courts. Users should note that the Data Access Committee bears no responsibility for the further analysis or interpretation of the published data.
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
Study ID | Study Title | Study Type |
---|---|---|
EGAS00001005891 | Other |
This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.